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We reported earlier that monocytes and macrophages from patients with type I Gaucher disease have a decreased capacity to generate
superoxide anion (O2
) on stimulation with opsonized S. aureus or formyl-methionyl-leucyl-phenylalanine. In this study, various forms of the
cell-free assay system were used to probe the hypothesis that glucocerebroside (GC) accumulating in Gaucher patients’ phagocytes may
interfere with the activation of NADPH oxidase. Xanthine/xanthine oxidase assay was applied to explore the possibility that GC may
scavenge O2
. We found that addition of GC to the crude, semirecombinant or fully purified cell-free systems inhibited activation of NADPH
oxidase in a concentration-dependent manner. The inhibitory effect of GC could be overcome by increased concentrations of p47phox and
p67phox. In contrast, O2
 generation was not decreased by GC added to the assembled, catalytically active enzyme complex. In the xanthine/
xanthine oxidase system, GC had no effect on the generation of O2
. These data indicate that assembly of the respiratory burst oxidase of
phagocytic cells may be a possible target of the pathologic actions of GC.
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In patients with Gaucher disease glucocerebroside (GC)
accumulates in lysosomes of monocytes and tissue macro-
phages resulting in hepatosplenomegaly, lymphadenopathy,
anemia, thrombocytopenia, and bone lesions [1,2]. In addi-
tion, these patients have increased susceptibility to bacterial
and viral infections which may be due to decreased bacteri-
cidal capacity and superoxide anion (O2
) production by
lipid-laden mononuclear phagocytes [3,4].
O2
 production by phagocytic cells is initiated by acti-
vation of the NADPH oxidase consisting of membrane-
bound (flavocytochrome b558) and cytosolic (p47
phox,
p67phox, p40phox and Rac) components [5,6]. In resting
cells, the membrane and cytosolic NADPH oxidase com-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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an inactive state. Specific stimuli acting on plasma mem-
brane receptors can lead to the activation of NADPH
oxidase through multi-step intracellular signaling [6,7].
Previously we and others [3,4] reported the impairment of
O2
 production initiated by opsonized bacteria or chemo-
tactic stimuli in monocytes and macrophages of Gaucher
patients. However, the potential step(s) of the intracellu-
lar signaling process affected by accumulation of GC
remained to be elucidated.
In this study, we probed the hypothesis that GC may
inhibit activation of NADPH oxidase. We studied the effect
of GC on the activation of NADPH oxidase in different cell-
free systems. We found that incubation of membrane and
cytosolic components with GC inhibited lipid-induced acti-
vation of NADPH oxidase in a concentration-dependent
manner. These data suggest that excess GC accumulation in
monocytes and macrophages in Gaucher patients may inter-
fere with the final step of the signaling cascade, the assembly
of the respiratory burst oxidase.
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2.1. Materials
Aprotinin, arachidonic-acid (AA), bovine serum albumin
(BSA), components of the LB medium, dimethyl sulfoxide
(DMSO), EGTA, ferricytochrome c (horse heart, type VI),
flavin adenine dinucleotide (FAD), GC, glutathione, gluta-
thione-agarose, leupeptin, NADPH, pepstatin, phenylme-
thylsulfonyl fluoride (PMSF), 1,2-didecanoyl-sn-glycerol
3-phosphate (phosphatidic acid, PA), N-2-hydroxyethylpi-
perazine-NV-2-ethanesulfonic acid (HEPES), sucrose, xan-
thine, xanthine-oxidase, and 1-oleoyl-2-acetylglycerol
(OAG) were purchased from Sigma (St. Louis, MO). Ficoll
Paquek Plus was obtained from Amersham Pharmacia
Biotech (Buckinghamshire, UK). Superoxide dismutase
(SOD) and GTPgS were from Boehringer Mannheim, iso-
propyl h-D-1-thiogalactopyranoside (IPTG) was from
Promega.
2.2. Expression vectors and recombinant oxidase
components
The E. coli clones producing p47phox and p67phox were a
generous gift of Dr. F. Wientjes. Recombinant p47phox and
p67phox were produced as glutathione-S-transferase (GST)-
fusion proteins in E. coli and purified as described [8].
Cytochrome b558 was purified and relipidated as described
[9]. Prenylated Rac was isolated from the membrane fraction
of Sf9 cells by extraction with 1% Chaps and purified as
described [10].
2.3. Isolation of neutrophils and subcellular fractions
Neutrophil granulocytes were isolated from buffy coat
by dextran sedimentation and centrifugation through
Ficoll Paquek Plus [11]. Cells were treated with diiso-
propyl fluorophosphate (DFP) for 10 min on ice, resus-
pended in sonication buffer (0.34 M sucrose, 10 mM
HEPES, 1 mM EGTA 1 mM PMSF, 100 AM leupeptin
in phosphate buffered saline (pH 7.0)) and broken by
sonication [12]. Sonicates were centrifuged (200 g, 10
min) to remove unbroken cells and nuclei, layered onto
a 17%/40% (w/v) discontinuous sucrose gradient and
centrifuged (100,000 g for 60 min) [12–14]. Cytosolic
fractions were collected from the top layer down to the
17%/40% interface and membrane fractions were col-
lected from the 17%/40% interface. Fractions were
stored at  70 jC. Protein concentration was determined
by the method of Bradford using BSA as standard
[15].
2.4. Measurement of O2
 generation in cell-free systems
The rate of superoxide generation was determined as
the SOD-inhibitable reduction of ferricytochrome c mea-sured at 550 nm in a Labsystems iEMS Microplate
Reader [12].
In the crude system, membranes (5 Ag) and cytosol
(50 Ag) were incubated in the presence of 125 AM
cytochrome c in a final volume of 80 Al PBS containing
1 mM MgCl2 and 20 AM FAD. Arachidonic acid (180
AM) or PA (375 AM) plus OAG (250 AM) were applied
as amphiphiles and GTPgS was added in 1 AM concen-
tration. O2
 production was initiated by the addition of
200 AM NADPH and followed for 20 min. The initial
linear portion of the absorption curves (lasting for 10–15
min) was used for calculation of the rate of O2

production. Parallel samples were run in the presence
of 100-Ag SOD. The absorption coefficient of ferricyto-
chrome c of 21000 M 1 cm 1 was used for calculation
of O2
 production.
In the semirecombinant system, membrane (5 Ag) and
recombinant p47phox (0.5 Ag; 87 nM) and recombinant
p67phox (0.5 Ag; 67 nM) were used instead of cytosol. The
membrane fraction isolated from human PMN contained
sufficient Rac as addition of either prenylated or non-preny-
lated Rac to the system did not influence the maximal rate of
O2
 production. The incubation was carried out in the pres-
ence of 180 AMAA or in the presence of 375 AMPA plus 250
AM OAG and 125 AM cytochrome c in a final volume of 80
Al. GTPgS was present in 1 AM concentration. O2 was
initiated by addition of 200 AM NADPH and followed for
20 min.
In the fully purified system, 0.005-Ag purified and
relipidated cytochrome b558 (0.6 nM) was incubated with
0.5-Ag p47phox (87 nM), 0.5-Ag p67phox (67 nM), 0.12-Ag
GTPgS-loaded prenylated Rac (60 nM), 125 AM OAG,
187.5 AM PA and 125 AM cytochrome c in a final
volume of 80 Al. O2 production was initiated by the
addition of 200 AM NADPH and followed for 20 min.
Conditions different from those described above are
indicated in the figure legend. GC was dissolved in
DMSO; its volume was kept at 1 Al and parallel solvent
controls were run in all experiments.
For loading of Rac with GTPgS, 1.8 Ag of the small
GTPase was incubated in a final volume of 22 Al of PBS
containing 4 mM EDTA and 30 AM GTPgS for 10 min
at 25 jC. Subsequently, 20 mM MgCl2 was added and
the protein was kept on ice [16].
2.5. Xanthine-oxidase assay
The assay was performed as described [14] with
slight modification. Xanthine (0.16 mM), xanthine-oxi-
dase (0.095 U/ml) and ferricytochrome c (80 AM) were
incubated with 250 AM NADPH in Krebs–Ringer
phosphate buffer with dextrose at 37 jC in a thermo-
stated spectrophotometer under stirring condition. The
amount of O2
 generated was measured by the SOD-
sensitive reduction of ferricytochrome c and expressed
as nmol O2
/min/mg xanthine oxidase [17].
Fig. 1. Effect of different concentrations of (GC) and ceramide (Cer) on
amphiphile-induced NADPH oxidase activity in crude (A), semirecombi-
nant (B) and fully purified (C) cell-free systems. At concentrations
indicated, GC or Cer was added before 180 AMAA in (A) and (B) or before
187.5 AM PA plus 125 AM OAG in (C). Results are expressed as the rate of
superoxide production. MeanF S.E.; n= 4 independent experiments carried
out in duplicates.
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3.1. Inhibition of NADPH oxidase activation by GC
In the crude activation system, various amounts of GC
were added to the membrane and cytosol fractions in the
presence of 1 AM GTPgS. Activation was induced by 180
AM AA and O2 generation was subsequently initiated by
200 AM NADPH. O2 generation was detected for 20 min,
during the assembly of the active NADPH oxidase complex.
As shown in Fig. 1 (panel A), GC inhibited O2
 generation
in a concentration-dependent manner.
The inhibitory effect of GC could be due to direct
interaction with the NADPH oxidase components. However,
it could also involve other components present in the cytosol
or in the membrane. Therefore, in the next step we applied a
semirecombinant in vitro system that is composed of the
membrane fraction (with associated Rac) and recombinant
p47phox and p67phox proteins, which replace completely the
cytosolic fraction. Similarly to the crude system, GC was
added before 180 AM AA, and O2 generation was elicited
by NADPH. The results indicated that similarly to the crude
system, in the presence of various concentrations of GC, O2

generation was also decreased in the semirecombinant
system (Fig. 1, panel B).
We investigated the effect of GC in the fully purified
system where the membrane fraction was replaced by
relipidated cytochrome b558 and GTPgS-loaded Rac, cor-
responding thus to a canonical cell-free system containing all
four essential components of the NADPH oxidase in purified
or recombinant form. Also in this system, GC brought about a
concentration-dependent decrease of O2
 generation. These
data suggest that GC may interact with one or several
components of the O2
-generating oxidase.
In cell-free systems, AA has a narrow optimal concen-
tration range, which is influenced by protein concentration,
ionic strength, or the presence of other lipids [18,19]. Thus,
GC may sequester AA and thereby mimic inhibition ofFig. 2. Effect of glucocerebroside on NADPH oxidase activity induced by
varying concentrations of arachidonic acid (AA) in the crude cell-free
system. Results represent the rate of O2
 generated in the absence (open
columns) or presence (shaded columns) of 105 AM GC added before AA.
MeanF S.E.; n= 5 independent experiments carried out in duplicates.
Fig. 3. Effect of glucocerebroside on NADPH oxidase activity induced by different concentrations of PA and OAG in the crude cell-free system. Results
represent the rate of superoxide generated in the absence (open columns) or presence (shaded columns) of GC added before the amphiphiles. MeanF S.E.;
n= 4 independent experiments carried out in duplicates.
Fig. 4. Effect of glucocerebroside (GC) on PA plus OAG-induced NADPH
oxidase activity in the fully purified cell-free system. GC was added 10 min
after the amphiphiles. Mean + S.E.; n= 4 independent experiments carried
out in duplicates.
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possibility that GC induces a shift of the optimal concen-
tration of AA. To this end, we tested the effect of GC in the
presence of various AA concentrations, ranging from 0 to
350 AM. As shown in Fig. 2, at all concentrations tested, O2
generation was lower in the presence of 105 AM GC than in
its absence. In addition, the optimal concentration of AA
remained between 150 and 200 AM and was not influenced
by the presence of GC.
As shown earlier, the combination of PA and diacylgly-
cerol induces high level of O2
 production in various forms of
the in vitro activation system [20,21]. The advantage of this
lipid combination is the broad optimal concentration range.
We performed experiments with two different concentrations
of PA and OAG as shown in Fig. 3. We found that addition of
GC before the amphiphiles resulted in significant decrease in
the detectable amount of O2
 independent of the applied
concentration of the amphiphiles. We obtained similar results
both in the crude (Fig. 3) and in the semirecombinant and
fully purified systems (data not shown).
In healthy individuals, GC is metabolized to ceramide
and glucose. Therefore, we raised the question whether
ceramide, the lipid with the closest structure to that of
GC, inhibits O2
 generation. Ceramide was applied under
the same condition as GC in all three types of the in vitro
activation system. In concentrations up to 1.12 mM (i.e. five
times higher than the highest concentration applied for GC),
ceramide did not inhibit O2
 generation (Fig. 1). Glucose,
the other degradation product of GC, did not affect the rate
of O2
 generation either (data not shown). Thus, the inhib-
itory effect on activation of phagocytic NADPH oxidase is
related to GC and not to its degradation products.
All these data suggest that GC is not acting by seques-
tering the amphiphile required to activate the cell-free
system but it may specifically inhibit components of the
NADPH oxidase.3.2. Mechanism of inhibition of NADPH oxidase by GC
In the preceding experiments we demonstrated that the
presence of GC during the activation phase of NADPH
oxidase inhibited O2
 generation. This effect of GC could be
due to interference with either the assembly of the NADPH
components or with electron transfer via the active enzyme
complex. In the following experiments, GC was added at a
time point when the active NADPH oxidase complex was
already assembled.
According to our previous experience, in the fully
purified system, activation of the enzyme is completed
in 10 min [12]. In the experiment shown in Fig. 4, GC
was added after a 10-min incubation period, simulta-
neously with NADPH. The results show that up to a
concentration of 105 AM, GC did not affect the rate of
Fig. 5. Effect of preincubation of the membrane fraction with GC on activation of the NADPH oxidase. The membrane fraction was preincubated with 210 AM
GC or its solvent for 10 min and then diluted to the reaction mixture of the semirecombinant system as described in Materials and methods. Non-pretreated
membranes were used in the presence of the indicated concentration of GC. MeanF S.E. of four independent experiments carried out in duplicates.
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 production in this system (Fig. 4). Similar results
were obtained in the crude and the semirecombinant
systems (data not shown). Thus, GC does not influence
the catalytic activity of the enzyme complex; it may
rather interfere with the assembly of NADPH oxidase
subunits.
We performed experiments to investigate whether GC
affects primarily the membrane-localized or the cytosolic
components of the NADPH oxidase. To this end, we first
designed an experiment to determine whether GC is
accumulated in the membrane fraction. As shown in
Fig. 5, the concentrated membrane fraction was preincu-
bated for 10 min with 210 AM GC and then diluted to
the usual reaction mixture containing the cytosolic com-
ponents and the cytochrome c. In this way, during the
activation of the enzyme, GC was present at a concen-Fig. 6. Effect of increased amounts of cytosolic components on the inhibitory actio
conditions detailed in Materials and methods (control) or with fivefold (+) or tenfo
the ratio (%) of values obtained in the presence of 105 AM GC and in its absenctration of 13 AM, well below its effective concentration
(column 3). The GC-pretreated membranes (column 5)
produced the same amount of O2
 as the control mem-
branes (column 1) whereas the presence of 210 AM GC
during the activation significantly reduced the detectable
O2
 production. Thus, GC is not likely to accumulate in
the membrane fraction but has to be present in the
activation phase to exert its inhibitory action.
Next we tested whether the inhibitory effect of GC can be
overcome by an increase of the amount of p47phox or p67phox
applied in the fully purified system (Fig. 6). GC at a
concentration of 105 AM reduced O2 production to 63%
of the initial rate. A five- or tenfold increase in the applied
amount of p47phox resulted in a rise of O2
 production to 79%
and 83% of the initial value. Augmentation of the amount of
p67phox had similar effect whereas addition of bovine serumn of GC. NADPH oxidase was activated in the fully purified system under
ld (++) higher amount of p47phox or p67phox. O2
 production is expressed as
e. MeanF S.E. of three experiments carried out in duplicates.
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interfere with the inhibitory action of GC (not shown).
3.3. Effect of GC on O2
 generation in the xanthine/xanthine
oxidase system
To explore the possibility of any O2
 scavenging effect of
GC, we used the xanthine/xanthine oxidase assay system.
The results showed that addition of GC (10–100 AM) to the
mixture of xanthine, xanthine oxidase, cytochrome c, and
NADPH failed to reduce the amount of O2
 released
(192 + 9 and 185 + 7 nmol/min/mg O2
 generated in the
presence and absence of 100 AM GC, respectively; n = 3).
These data suggest that GC may not scavenge reactive
oxygen radicals.4. Discussion
In Gaucher disease, deficient activity of the lysosomal
hydrolase, glucocerebrosidase, results in accumulation of
undegraded GC in mononuclear phagocytes. The progres-
sive deposition of GC in macrophages in different organs is
responsible for signs and symptoms of the disease. Howev-
er, fundamental questions remain, regarding how macro-
phage functions altered by GC contribute to the course of
the disease. Macrophages play a key role in host defense
against various extracellular and intracellular organisms.
The most striking and consistent immunologic feature in
Gaucher patients is the decreased capacity of mononuclear
phagocytes to kill viable microorganisms [3,4]. Deficiency
in bactericidal capacity by these cells may be due to
decreased O2
 production [3,4]. However, the biochemical
basis of the decreased O2
 production by Gaucher mono-
cytes and macrophages has not been previously studied in
detail. To define possible molecular targets of GC in
phagocytic cells, we investigated the effect of this com-
pound in different cell-free systems. In this study, we
demonstrated that GC inhibited activation of NADPH
oxidase in mixtures of membrane and cytosolic components
of the oxidase in a concentration-dependent manner.
Several lines of evidence from this work point to GC as a
specific inhibitor of NADPH oxidase. In the crude and
semirecombinant systems, AA was used to initiate NADPH
oxidase activity. AA may activate NADPH oxidase by direct
interaction with the p47phox enzyme component [22,23].
One possible explanation for the inhibitory effect of GC in
the cell-free systems we used could be that GC as a
hydrophobic compound might also interact with AA. How-
ever, we showed here that increasing the concentration of
AA in the cell-free system did not overcome the inhibitory
effect of GC, and GC was inhibitory for NADPH oxidase
activation over a wide range of AA concentration tested. In
addition, GC was also inhibitory when PA and OAG were
used to induce NADPH oxidase, independent of the con-
centration of these amphiphiles. Ceramide, a related com-pound, was not inhibitory in the cell-free system, suggesting
specificity in the effect of GC.
In contrast to the activation phase, we could not detect
any decrease in O2
 production when GC was added to the
assembled NADPH oxidase. These data suggest that GC has
no inhibitory effect on the catalytic function of the enzyme
complex. GC does not accumulate in the membrane phase
but its effect can be overcome by increasing the amount of
the cytosolic phox components. We thus propose that
through physico-chemical interactions, GC may prevent
the proper alignment of NADPH oxidase components that
is required for optimal O2
 production. Details of the binding
of cytosolic subunits to GC and potential interference with
their translocation have to be investigated in separate
studies.
In patients with Gaucher disease, accumulation of GC in
various subcellular compartments may interfere with the
assembling process of the NADPH oxidase, providing an
explanation for earlier observations on impairment of O2

production and possibly contributing to the decreased bac-
terial killing activity of patients’ mononuclear phagocytes.
As shown previously, enzyme replacement therapy resulted
in partial restoration of both the O2
S  production and the
bactericidal capacity [4].Acknowledgements
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